Corticotropin-releasing factor receptor antagonist attenuates LPS-induced increase of GTP cyclohydrolase I expression at murine locus coeruleus

Yoko S. Kaneko, Keiji Mori, Akira Nakashima, Ikuko Nagatsu, Toshiharu Nagatsu, Akira Ota

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

It has been reported that corticotropin-releasing factor (CRF) is involved in the regulation of norepinephrine neuron responses to stress such as an immobilized stress. Furthermore, systemic lipopolysaccharide (LPS) injection upregulates the transcription of the genes encoding CRF and CRF type 1 receptor in the paraventricular nucleus of the hypothalamus. We have already reported that an increase in norepinephrine turnover within the murine locus coeruleus is accompanied by septic shock triggered by LPS intraperitoneal injection. We also elucidated that the expression levels of the enzymes involved in the catecholamine biosynthesis were altered by peripheral LPS injection. Collectively, the effects of CRF on the expression levels of the enzymes at murine locus coeruleus were investigated by peripherally injecting CP-154,526, a CRF receptor type 1 antagonist. Pretreatment with CP-154,526 attenuated the increase in expression levels of GTP cyclohydrolase I mRNA due to intraperitoneal LPS injection at 4 h after the injection. However, no effects on the expression level of tyrosine hydroxylase mRNA at the site were observed. Taken together with the fact that LPS injection enhances tetrahydrobiopterin biosynthesis at locus coeruleus, CP-154,526 may attenuate the increase of NE turnover by suppressing the enhanced GCH expression level at the site caused by peripheral LPS injection.

Original languageEnglish
Pages (from-to)289-297
Number of pages9
JournalBiogenic Amines
Volume19
Issue number4-6
DOIs
Publication statusPublished - 01-12-2005

Fingerprint

GTP Cyclohydrolase
Corticotropin-Releasing Hormone Receptors
Locus Coeruleus
Lipopolysaccharides
Corticotropin-Releasing Hormone
Injections
Intraperitoneal Injections
Norepinephrine
Messenger RNA
Paraventricular Hypothalamic Nucleus
Tyrosine 3-Monooxygenase
Enzymes
Septic Shock
Hypothalamus
Catecholamines
Up-Regulation
Neurons
Genes

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Pharmacology

Cite this

Kaneko, Yoko S. ; Mori, Keiji ; Nakashima, Akira ; Nagatsu, Ikuko ; Nagatsu, Toshiharu ; Ota, Akira. / Corticotropin-releasing factor receptor antagonist attenuates LPS-induced increase of GTP cyclohydrolase I expression at murine locus coeruleus. In: Biogenic Amines. 2005 ; Vol. 19, No. 4-6. pp. 289-297.
@article{fa1ee690b6634676aa208b49b503d66b,
title = "Corticotropin-releasing factor receptor antagonist attenuates LPS-induced increase of GTP cyclohydrolase I expression at murine locus coeruleus",
abstract = "It has been reported that corticotropin-releasing factor (CRF) is involved in the regulation of norepinephrine neuron responses to stress such as an immobilized stress. Furthermore, systemic lipopolysaccharide (LPS) injection upregulates the transcription of the genes encoding CRF and CRF type 1 receptor in the paraventricular nucleus of the hypothalamus. We have already reported that an increase in norepinephrine turnover within the murine locus coeruleus is accompanied by septic shock triggered by LPS intraperitoneal injection. We also elucidated that the expression levels of the enzymes involved in the catecholamine biosynthesis were altered by peripheral LPS injection. Collectively, the effects of CRF on the expression levels of the enzymes at murine locus coeruleus were investigated by peripherally injecting CP-154,526, a CRF receptor type 1 antagonist. Pretreatment with CP-154,526 attenuated the increase in expression levels of GTP cyclohydrolase I mRNA due to intraperitoneal LPS injection at 4 h after the injection. However, no effects on the expression level of tyrosine hydroxylase mRNA at the site were observed. Taken together with the fact that LPS injection enhances tetrahydrobiopterin biosynthesis at locus coeruleus, CP-154,526 may attenuate the increase of NE turnover by suppressing the enhanced GCH expression level at the site caused by peripheral LPS injection.",
author = "Kaneko, {Yoko S.} and Keiji Mori and Akira Nakashima and Ikuko Nagatsu and Toshiharu Nagatsu and Akira Ota",
year = "2005",
month = "12",
day = "1",
doi = "10.1163/156939105774647411",
language = "English",
volume = "19",
pages = "289--297",
journal = "Biogenic Amines",
issn = "0168-8561",
publisher = "Society of Integrated Sciences",
number = "4-6",

}

Corticotropin-releasing factor receptor antagonist attenuates LPS-induced increase of GTP cyclohydrolase I expression at murine locus coeruleus. / Kaneko, Yoko S.; Mori, Keiji; Nakashima, Akira; Nagatsu, Ikuko; Nagatsu, Toshiharu; Ota, Akira.

In: Biogenic Amines, Vol. 19, No. 4-6, 01.12.2005, p. 289-297.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Corticotropin-releasing factor receptor antagonist attenuates LPS-induced increase of GTP cyclohydrolase I expression at murine locus coeruleus

AU - Kaneko, Yoko S.

AU - Mori, Keiji

AU - Nakashima, Akira

AU - Nagatsu, Ikuko

AU - Nagatsu, Toshiharu

AU - Ota, Akira

PY - 2005/12/1

Y1 - 2005/12/1

N2 - It has been reported that corticotropin-releasing factor (CRF) is involved in the regulation of norepinephrine neuron responses to stress such as an immobilized stress. Furthermore, systemic lipopolysaccharide (LPS) injection upregulates the transcription of the genes encoding CRF and CRF type 1 receptor in the paraventricular nucleus of the hypothalamus. We have already reported that an increase in norepinephrine turnover within the murine locus coeruleus is accompanied by septic shock triggered by LPS intraperitoneal injection. We also elucidated that the expression levels of the enzymes involved in the catecholamine biosynthesis were altered by peripheral LPS injection. Collectively, the effects of CRF on the expression levels of the enzymes at murine locus coeruleus were investigated by peripherally injecting CP-154,526, a CRF receptor type 1 antagonist. Pretreatment with CP-154,526 attenuated the increase in expression levels of GTP cyclohydrolase I mRNA due to intraperitoneal LPS injection at 4 h after the injection. However, no effects on the expression level of tyrosine hydroxylase mRNA at the site were observed. Taken together with the fact that LPS injection enhances tetrahydrobiopterin biosynthesis at locus coeruleus, CP-154,526 may attenuate the increase of NE turnover by suppressing the enhanced GCH expression level at the site caused by peripheral LPS injection.

AB - It has been reported that corticotropin-releasing factor (CRF) is involved in the regulation of norepinephrine neuron responses to stress such as an immobilized stress. Furthermore, systemic lipopolysaccharide (LPS) injection upregulates the transcription of the genes encoding CRF and CRF type 1 receptor in the paraventricular nucleus of the hypothalamus. We have already reported that an increase in norepinephrine turnover within the murine locus coeruleus is accompanied by septic shock triggered by LPS intraperitoneal injection. We also elucidated that the expression levels of the enzymes involved in the catecholamine biosynthesis were altered by peripheral LPS injection. Collectively, the effects of CRF on the expression levels of the enzymes at murine locus coeruleus were investigated by peripherally injecting CP-154,526, a CRF receptor type 1 antagonist. Pretreatment with CP-154,526 attenuated the increase in expression levels of GTP cyclohydrolase I mRNA due to intraperitoneal LPS injection at 4 h after the injection. However, no effects on the expression level of tyrosine hydroxylase mRNA at the site were observed. Taken together with the fact that LPS injection enhances tetrahydrobiopterin biosynthesis at locus coeruleus, CP-154,526 may attenuate the increase of NE turnover by suppressing the enhanced GCH expression level at the site caused by peripheral LPS injection.

UR - http://www.scopus.com/inward/record.url?scp=29444432818&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=29444432818&partnerID=8YFLogxK

U2 - 10.1163/156939105774647411

DO - 10.1163/156939105774647411

M3 - Article

VL - 19

SP - 289

EP - 297

JO - Biogenic Amines

JF - Biogenic Amines

SN - 0168-8561

IS - 4-6

ER -